HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Efficacy of lenalidomide treatment and complete cytogenetic remission in a case of myelodysplastic syndrome with del(5q) and del(9q).

AuthorsBei Xiong, XinYue Liu, Ping Zou, LiHua Fan, WanXin Chen, WeiMing Li, Lin Liu
JournalLeukemia research (Leuk Res) Vol. 34 Issue 7 Pg. e169-72 (Jul 2010) ISSN: 1873-5835 [Electronic] England
PMID20122730 (Publication Type: Case Reports, Letter)
Chemical References
  • Angiogenesis Inhibitors
  • Immunologic Factors
  • Thalidomide
  • Lenalidomide
Topics
  • Aged
  • Angiogenesis Inhibitors (therapeutic use)
  • Bone Marrow (pathology)
  • Chromosome Deletion
  • Chromosomes, Human, Pair 5 (ultrastructure)
  • Chromosomes, Human, Pair 9 (ultrastructure)
  • Female
  • Humans
  • Immunologic Factors (therapeutic use)
  • Lenalidomide
  • Myelodysplastic Syndromes (drug therapy, genetics)
  • Neoplasm, Residual
  • Remission Induction
  • Thalidomide (analogs & derivatives, therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: